Skip to main content
. 2023 Oct 11;15(2):2265028. doi: 10.1080/19490976.2023.2265028

Figure 2.

Figure 2.

Summary of the roles of gut microbiota and relevant therapeutic applications in four common EIMs. EIM, extra-intestinal manifestation; PSC, primary sclerosing cholangitis; MLN, mesenteric lymph node; BA, bile acid; PBA, primary bile acid; SBA, secondary bile acid; DCA, deoxycholic acid; CA, cholic acid; AAU, acute anterior uveitis; LPS, lipopolysaccharide; SCFA, short-chain fatty acid; iFABP, intestinal fatty acid binding protein; TMAO, trimethylamine N-oxide; TNF-α, tumor necrosis factor-α; IL-17, interleukin-17.